-
REAL-WORLD EFFECTIVENESS AND RESOURCE UTILIZATION OF CORTICOSTEROIDS IN HOSPITALIZED COVID-19 PATIENTS: A RETROSPECTIVE STUDY FROM SOUTH INDIA
Feb 25, 2026, 14:41 PM -
VALIDATION OF THE METASLR ROB MODULE: A MULTI-AGENT GENERATIVE AI SYSTEM FOR AUTOMATING COCHRANE RISK OF BIAS 2.0 ASSESSMENTS
Feb 25, 2026, 14:41 PM -
ORGANIZATIONAL AND BUDGET IMPACT MODEL (OBIM) OF A NATIONAL SCREENING PROGRAM FOR PRECLINICAL TYPE 1 DIABETES (T1D) IN FRANCE
Feb 25, 2026, 14:41 PM -
DOES ARTIFICIAL INTELLIGENCE IMPROVE OUTCOMES IN ACUTE ISCHEMIC STROKE CARE?
Feb 25, 2026, 14:41 PM -
REAL-WORLD PATTERNS OF CTDNA TESTING, MOLECULAR RESIDUAL DISEASE, AND TREATMENT AFTER RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
Feb 25, 2026, 14:41 PM -
DO INTRA-ARTICULAR INJECTIONS IMPROVE QUALITY OF LIFE MORE THAN PHYSIOTHERAPY IN KNEE OSTEOARTHRITIS:EVIDENCE FROM AN UPPER-MIDDLE-INCOME COUNTRY
Feb 25, 2026, 14:41 PM -
INFLATION REDUCTION ACT NEGOTIATIONS: QUALITATIVE INSIGHTS FROM 25 PART D DRUG PRICE NEGOTIATIONS
Feb 25, 2026, 14:41 PM -
FORMULARY EXCLUSIONS AND NON-ADHERENCE TO DISEASE-MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS IN MEDICARE PART D
Feb 25, 2026, 14:41 PM -
THE ROLE OF SYSTEMIC INFLAMMATION IN THE ASSOCIATION OF OBESITY WITH MORTALITY AND HEALTH OUTCOMES AMONG COPD PATIENTS: A MEDIATION ANALYSIS
Feb 25, 2026, 14:41 PM -
ASSESSING THE RETURN ON INVESTMENT (ROI) OF HEOR & RWE TO THE BIOPHARMACEUTICAL INDUSTRY: CASE EXAMPLE OF COMPARATIVE EFFECTIVENESS RESEARCH USING SECONDARY RWD SOURCES
Feb 25, 2026, 14:41 PM -
STREAMLINING KIDNEY TRANSPLANT COORDINATION THROUGH PROCESS MAPPING: IMPROVING TIMELINESS, REGULATORY COMPLIANCE, AND ORGAN UTILISATION IN A TERTIARY HOSPITAL
Feb 25, 2026, 14:41 PM -
RISKY BUSINESS: HOW HEALTH PREFERENCE RESEARCH CAPTURES RISK TOLERANCE
Feb 25, 2026, 14:41 PM -
CARDIOVASCULAR RISK STRATIFICATION USING UNSUPERVISED MACHINE LEARNING IN BREAST CANCER PATIENTS, INITIATING ANTHRACYCLINE-BASED TREATMENTS
Feb 25, 2026, 14:41 PM -
2026 REVIEW OF GENE THERAPY ACCESS LANDSCAPE
Feb 25, 2026, 14:41 PM -
ACCESS TO CARE, QUALITY OF LIFE AND MENTAL HEALTH SERVICE UTILIZATION AMONG US ADULTS WITH DEPRESSION
Feb 25, 2026, 14:41 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
COST ANALYSIS AND HEALTHCARE RESOURCE UTILIZATION AFTER OPEN LIVER RESECTION FROM A RANDOMIZED CONTROL TRIAL
Feb 25, 2026, 14:41 PM -
DECISION MODEL EVALUATING CLINICAL EVENT-RELATED COSTS OF PERSISTING WITH APIXABAN COMPARED WITH SWITCHING TO RIVAROXABAN AFTER A BLEEDING EVENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY
Feb 25, 2026, 14:41 PM -
REAL-WORLD TREATMENT PATTERNS IN COMMERCIALLY INSURED PATIENTS WITH RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER (EC) IN THE USA
Feb 25, 2026, 14:41 PM
